All News

FDA has expanded the use of telavancin (Vibativ, Theravance) to treat adult patients with hospital-acquired and ventilator-associated bacterial pneumonia caused by susceptible isolates of Staphylococcus aureus when alternative treatments are not suitable.

When it comes to taking medication properly, Americans 40 and older with chronic medical conditions, on average, earn a C+, according to a patient survey commissioned by the National Community Pharmacists Association.

Adding more than a one-half serving of red meat daily for 4 years can increase the risk of type 2 diabetes mellitus over the subsequent 4-year period, according to a report published online June 17 for JAMA Internal Medicine.

The Centers for Disease Control and Prevention (CDC) recommended preexposure prophylaxis (PrEP) to injection drug users who are at high risk of HIV infection, following the positive results of the Bangkok Tenovir Study, published online June 12 in the Lancet.

Former Health and Human Services Secretary Tommy Thompson is leading a group that wants greater FDA oversight of compounding pharmacies, including restrictions on the drugs they can produce.

FDA has approved the use of Plan B One-Step (levonorgestrel) as a nonprescription product for all women of child-bearing potential. This action complies with the April 5, 2013 order of the United States District Court in New York to make levonorgestrel-containing emergency contraceptives available as an over-the-counter (OTC) product without age or point-of-sale restrictions.

FDA approved a test that identifies the genotype of hepatitis C virus (HCV) that a patient is carrying.

APhA DrugInfoLine, an online publication that provides drug-news updates to members of the American Pharmacists Association (APhA), has named Kristin W. Weitzel editor-in-chief.

The effectiveness of new drugs compared with that of older drugs has fallen since the 1970s, according to a new study in Health Affairs.

Janet Silvester, former president and board member of the American Society of Health-System Pharmacists (ASHP), will rejoin that organization as its vice president of accreditation services.

FDA approved the expanded use of denosumab (Xgeva, Amgen) to treat adults and some adolescents with giant cell tumor of the bone (GCTB), a rare and usually non-cancerous tumor.

FDA is investigating 2 unexplained deaths in patients who received an intramuscular injection of the antipsychotic drug Zyprexa Relprevv (olanzapine pamoate), according to an FDA Drug Safety Communication.

The U.S. Supreme Court today ruled that pay-for-delay agreements between brand name drug companies and generic manufacturers are subject to antitrust scrutiny.

The Center for Medicare and Medicaid Services (CMS) is seeking comments on its proposed rule on the Health Insurance Marketplace set forth by the Affordable Care Act.

More face-to-face interaction between pharmacists and patients would reduce chronic diseases, cut healthcare costs, and lessen the misuse of medications, according to a May 21 white paper by RxAlly.

How to handle the folks who think that none of the rules apply to them

Two new analyses result in conflicting findings

Even with inadequate help and pressure from above, the pharmacist must always put the patient first

Doctors would have to prescribe antibiotics to 12,000 patients diagnosed with common colds to prevent one hospital admission for pneumonia, study shows

Remember that Nike ad? Just do it!

Advocacy and education will change attitudes

Patient-centered outcomes research makes pharmacists even more important members of the healthcare team

As you fill the Rx for that "little blue pill," use the opportunity to tell patients that ED can be a precursor of heart disease

Six steps compounding pharmacies can take to create and maintain a culture of quality assurance

"Compounders" and "compounding manufacturers" defined

Approval requires canagliflozin manufacturer to complete five post-marketing studies

Through patient education and screening processes, pharmacists can identify and support underserved patients with mental illness

Drug Topics readers weigh in

FDA asks stakeholders to weigh in on solutions